Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention-prospective, single-center, randomized, parallel-group study.
Kashiwada T, Tanaka Y, Tanaka T, Okano T, Saito Y, Seike M, Hino M, Kimura H, Gemma A. Kashiwada T, et al. Among authors: gemma a. BMC Pulm Med. 2024 Feb 17;24(1):90. doi: 10.1186/s12890-024-02895-0. BMC Pulm Med. 2024. PMID: 38368315 Free PMC article. Clinical Trial.
Identification of kynurenine and quinolinic acid as promising serum biomarkers for drug-induced interstitial lung diseases.
Sun Y, Saito K, Ushiki A, Abe M, Saito Y, Kashiwada T, Horimasu Y, Gemma A, Tatsumi K, Hattori N, Tsushima K, Takemoto K, Ishikawa R, Momiyama T, Matsuyama SI, Arakawa N, Akane H, Toyoda T, Ogawa K, Sato M, Takamatsu K, Mori K, Nishiya T, Izumi T, Ohno Y, Saito Y, Hanaoka M. Sun Y, et al. Among authors: gemma a. Respir Res. 2024 Jan 14;25(1):31. doi: 10.1186/s12931-023-02653-6. Respir Res. 2024. PMID: 38221627 Free PMC article.
Carboplatin and weekly paclitaxel in combination with bevacizumab for the treatment of advanced non-small cell lung cancer complicated by idiopathic interstitial pneumonias: A feasibility study.
Omori M, Minegishi Y, Uruga H, Fukuizumi A, Isobe K, Izumi S, Koyama R, Bando M, Sugiyama H, Takahashi K, Gemma A, Homma S, Sugiyama Y, Kishi K. Omori M, et al. Among authors: gemma a. Respir Investig. 2023 Sep;61(5):625-631. doi: 10.1016/j.resinv.2023.06.002. Epub 2023 Jul 11. Respir Investig. 2023. PMID: 37441903 Clinical Trial.
Full thermoelectric characterization of a single molecule.
Gemma A, Tabatabaei F, Drechsler U, Zulji A, Dekkiche H, Mosso N, Niehaus T, Bryce MR, Merabia S, Gotsmann B. Gemma A, et al. Nat Commun. 2023 Jun 30;14(1):3868. doi: 10.1038/s41467-023-39368-7. Nat Commun. 2023. PMID: 37391406 Free PMC article.
Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study.
Kogure Y, Kada A, Hashimoto H, Atagi S, Takiguchi Y, Saka H, Ebi N, Inoue A, Kurata T, Fujita Y, Nishii Y, Itani H, Endo T, Saito AM, Shibayama T, Yamamoto N, Gemma A. Kogure Y, et al. Among authors: gemma a. JTO Clin Res Rep. 2023 Apr 6;4(6):100514. doi: 10.1016/j.jtocrr.2023.100514. eCollection 2023 Jun. JTO Clin Res Rep. 2023. PMID: 37304652 Free PMC article.
The "Lazio ADVICE" telemedicine platform: First results of general practitioners' usage, facilitators and barriers in the Local Health Authority Roma 1.
Barbara A, Villani L, Lombardo P, Parente P, Gemma A, Angeletti D, Chiriaco T, Mastromattei A, Akselrod S, Goletti M, Rosa ED, De Vito C. Barbara A, et al. Among authors: gemma a. Digit Health. 2023 May 24;9:20552076231174099. doi: 10.1177/20552076231174099. eCollection 2023 Jan-Dec. Digit Health. 2023. PMID: 37256007 Free PMC article.
Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients.
Tozuka T, Yanagitani N, Yoshida H, Manabe R, Ogusu S, Tsugitomi R, Sakamoto H, Amino Y, Ariyasu R, Uchibori K, Kitazono S, Seike M, Gemma A, Nishio M. Tozuka T, et al. Among authors: gemma a. Invest New Drugs. 2023 Jun;41(3):411-420. doi: 10.1007/s10637-023-01358-3. Epub 2023 Apr 14. Invest New Drugs. 2023. PMID: 37058183
Effectiveness and Safety of Atezolizumab Monotherapy in Previously Treated Japanese Patients With Unresectable Advanced or Recurrent NSCLC: A Multicenter, Prospective, Observational Study (J-TAIL).
Miura S, Nishio M, Akamatsu H, Goto Y, Hayashi H, Gemma A, Yoshino I, Misumi T, Hata A, Hataji O, Fujita K, Seike M, Yanagitani N, Nishino K, Hara S, Saito R, Mori M, Tsuda T, Iwasawa S, Nakagawa S, Mitsudomi T. Miura S, et al. Among authors: gemma a. JTO Clin Res Rep. 2023 Feb 24;4(3):100484. doi: 10.1016/j.jtocrr.2023.100484. eCollection 2023 Mar. JTO Clin Res Rep. 2023. PMID: 37034464 Free PMC article.
423 results